[VRTX] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
31-Oct-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -78.49%
YoY- -55.32%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 2,334,300 1,984,164 1,538,271 949,828 784,535 578,165 413,783 33.40%
PBT 1,176,400 1,082,741 745,871 70,666 136,511 -417,170 -42,034 -
Tax 245,900 230,813 78,437 13,148 8,055 -125,903 503 180.53%
NP 930,500 851,928 667,434 57,518 128,746 -102,952 -41,841 -
Tax Rate -20.90% -21.32% -10.52% -18.61% -5.90% - - -
Total Cost 1,403,800 1,132,236 870,837 892,310 655,789 681,117 455,624 20.61%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 39.86 42.94 43.39 6.06 16.41 -17.81 -10.11 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 3.63 3.30 2.56 0.22 0.51 -0.41 -0.17 -
EPS Diluted 3.59 3.28 2.53 0.22 0.50 -0.41 -0.17 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.